Stavudine in antiretroviral therapy: is this the end?-Reference-Cited by-同舟云学术

Stavudine in antiretroviral therapy: is this the end?

Published:2009-08-24 Issue:13 Volume:23 Page:1727-1729
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Brinkman Kees

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference14 articles.

1. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors;Carr;AIDS,1998

2. Mitochondrial toxicity induced by nucleoside-analogue reverse- transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy;Brinkman;Lancet,1999

3. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level;Nolan;Antiviral Ther,2003

4. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study;Saint-Marc;AIDS,2000

5. Increased risk of lipoatrophy under stavudine in HIV-1 infected patients: results of a substudy from a comparative trial;Joly;AIDS,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Tenofovir Versus Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study;The Open AIDS Journal;2017-01-23

2. Implementing a Tenofovir-Based First-Line Regimen in Rural Lesotho: Clinical Outcomes and Toxicities After Two Years;JAIDS Journal of Acquired Immune Deficiency Syndromes;2011-03-01

3. The first decade of antiretroviral therapy in Africa;Globalization and Health;2011

4. A Randomized Factorial Trial Comparing 4 Treatment Regimens in Treatment‐Naive HIV‐Infected Persons with AIDS and/or a CD4 Cell Count <200 Cells/μL in South Africa;The Journal of Infectious Diseases;2010-11-15

5. Improving first-line antiretroviral therapy in resource-limited settings;Current Opinion in HIV and AIDS;2010-01